Literature DB >> 2739828

Familial thin basement membrane nephropathy in children with asymptomatic microhematuria.

B Gauthier1, H Trachtman, R Frank, E Valderrama.   

Abstract

A review of 130 children with persistent microhematuria showed that the most common abnormality was a form of hereditary nephritis for wich we propose the term 'familial thin basement membrane nephropathy' (FTBMN). This lesion is not as severe as that of Alport's syndrome but carries a guarded prognosis. Family histories, urinalyses and audiograms systematically done on parents and other relatives show that FTBMN may be present in as many as 39% of children with persistent microhematuria and that careful family studies identify children likely to have this lesion.

Entities:  

Mesh:

Year:  1989        PMID: 2739828     DOI: 10.1159/000185384

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.

Authors:  D H Cohn; T Shohat; M Yahav; T Ilan; G Rechavi; L King; M Shohat
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

2.  Asymptomatic hematuria.

Authors:  B Gauthier; H Trachtman
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

3.  Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

Authors:  H H Lemmink; W N Nillesen; T Mochizuki; C H Schröder; H G Brunner; B A van Oost; L A Monnens; H J Smeets
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

4.  Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.

Authors:  Kesha Rana; Yan Yan Wang; Harley Powell; Colin Jones; David McCredie; Mark Buzza; Madhara Udawela; Judy Savige
Journal:  Pediatr Nephrol       Date:  2005-10-19       Impact factor: 3.714

5.  Erythrocyte deformability and microhematuria in children and adolescents.

Authors:  Anamarija Meglic; Drago Kuzman; Janez Jazbec; Barbara Japelj-Pavesić; Rajko B Kenda
Journal:  Pediatr Nephrol       Date:  2003-01-17       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.